Philipp Knechtle

Years Active: 2020-2020
Publications (10 Years): 3

discoveric bio beta Ltd

This page only lists publications with an associated author ORCID identifier.

Affiliation History

discoveric bio beta Ltd May 01 2020

Switzerland

Chief Scientific Officer

Allecra Therapeutics SAS Feb 01 2017 - Apr 15 2020

France

Head of Microbiology

Publications

Shampa Das, Richard Fitzgerald, Asad Ullah, Marcin Bula, Andrea M Collins, Elena Mitsi, Jesus Reine, Helen Hill, Jamie Rylance, Daniela M Ferreira, Karen Tripp, Andrea Bertasini, Samantha Franzoni, Mameli Massimiliano, Omar Lahlou, Paola Motta, Philip Barth, Patrick Velicitat, Philipp Knechtle, William W Hope
Intrapulmonary Pharmacokinetics of Cefepime and Enmetazobactam in Healthy Volunteers: Towards New Treatments for Nosocomial Pneumonia. Antimicrobial agents and chemotherapy 65 (1) (2020)
Adam Johnson, Laura McEntee, Nicola Farrington, Ruwanthi Kolamunnage-Dona, Samantha Franzoni, Alberto Vezzelli, Mameli Massimiliano, Philipp Knechtle, Adam Belley, Aaron Dane, George Drusano, Shampa Das, William W Hope
Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing Klebsiella pneumoniae. Antimicrobial agents and chemotherapy 64 (6) (2020)
Fabian Bernhard, Rajesh Odedra, Sylvie Sordello, Rossella Cardin, Samantha Franzoni, Cédric Charrier, Adam Belley, Peter Warn, Matthias Machacek, Philipp Knechtle
Pharmacokinetics-Pharmacodynamics of Enmetazobactam Combined with Cefepime in a Neutropenic Murine Thigh Infection Model. Antimicrobial agents and chemotherapy 64 (6) (2020)

Philipp Knechtle.css-eqlu8i{font-size:small;padding-left:4px;}